AMBA vs REGN · rev $284.9M vs P/E 14, rev $14.34B
Ambarella Inc (AMBA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Ambarella Inc (AMBA) is a semiconductor equipment & materials company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AMBA revenue for 2025-01-31 was $284.9M. Net income was -$117.1M. Revenue was up 25.8% from 2024-01-31 to 2025-01-31. AMBA currently screens at market cap $2.86B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AMBA currently screens at market cap $2.86B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AMBA and REGN stock pages for the full models.
Not investment advice.